Kindred Biosciences, Inc.KINNASDAQ
LOADING
|||
PE Ratio: Premium Valuation
Trending lower, above historical average, structural decline.
Left:
||||
Price-to-earnings ratio
Latest
-7.17
↑ 88% above average
Average (8y)
-57.52
Historical baseline
Range
High:-2.48
Low:-469.37
CAGR
-40.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2020 | -7.17 | -34.2% |
| 2019 | -5.34 | +21.8% |
| 2018 | -6.83 | +11.0% |
| 2017 | -7.68 | -104.5% |
| 2016 | -3.75 | -51.5% |
| 2015 | -2.48 | +51.9% |
| 2014 | -5.16 | +47.9% |
| 2013 | -9.89 | +97.9% |
| 2012 | -469.37 | - |